Equillium, Inc. (EQ)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
---|---|---|---|---|
Recognized revenue | - | - | 12,161 | |
Research and development | 4,083 | 5,924 | 9,562 | |
General and administrative | 2,145 | 2,946 | 3,278 | |
Total operating expenses | 6,228 | 8,870 | 12,840 | |
Loss from operations | -6,228 | -8,870 | -679 | |
Other income (expense), net | 367 | 43 | 341 | |
Interest income | 122 | 173 | 331 | |
Total other income, net | 489 | 216 | 672 | |
Loss before income taxes | - | - | -7 | |
Net (loss) income | -5,739 | -8,654 | -7 | |
Unrealized loss on available-for-sale securities, net | - | -3 | 21 | |
Foreign currency translation (loss) gain | -346 | -47 | -275 | |
Total other comprehensive (loss) income, net | -346 | -50 | -254 | |
Comprehensive loss | -6,085 | -8,704 | -261 | |
Earnings per share, basic | -0.16 | -0.24 | - | |
Earnings per share, diluted | -0.16 | -0.24 | - | |
Weighted average number of shares outstanding, basic | 35,719,317 | 35,586,861 | 35,424,388 | |
Weighted average number of shares outstanding, diluted | 35,719,317 | 35,586,861 | 35,424,388 |